| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.69T | 48.04T | 45.10T | 37.15T | 31.38T | 27.21T |
| Gross Profit | 8.93T | 9.58T | 9.37T | 6.31T | 5.97T | 4.83T |
| EBITDA | 7.34T | 8.75T | 9.12T | 5.76T | 5.84T | 4.62T |
| Net Income | 3.72T | 4.77T | 4.94T | 2.45T | 2.85T | 2.25T |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 93.60T | 90.11T | 74.30T | 67.69T | 67.69T |
| Cash, Cash Equivalents and Short-Term Investments | 7.92T | 15.92T | 14.11T | 9.23T | 8.62T | 8.62T |
| Total Debt | 42.16T | 38.79T | 36.56T | 29.38T | 26.50T | 26.50T |
| Total Liabilities | 62.39T | 56.72T | 54.87T | 45.04T | 40.53T | 40.53T |
| Stockholders Equity | 39.00T | 35.92T | 34.22T | 28.34T | 26.25T | 26.25T |
Cash Flow | ||||||
| Free Cash Flow | 166.16B | -1.56T | -842.02B | -750.76B | -107.63B | -7.19B |
| Operating Cash Flow | 4.64T | 3.70T | 4.21T | 2.96T | 3.72T | 25.71B |
| Investing Cash Flow | -5.00T | -4.19T | -5.00T | -1.60T | -577.50B | -44.17B |
| Financing Cash Flow | -18.44B | 197.24B | 2.50T | -56.18B | -2.47T | 25.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $313.42B | 12.86 | 10.34% | 2.57% | 7.28% | 12.41% | |
63 Neutral | $41.68B | 12.48 | 4.11% | 4.19% | 0.32% | -25.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | $1.54T | 382.63 | 4.89% | ― | -2.93% | -47.22% | |
57 Neutral | $75.63B | 25.60 | 4.34% | 0.69% | -1.29% | -49.96% | |
56 Neutral | $55.25B | -7.19 | -20.26% | 5.64% | 3.75% | 33.37% | |
55 Neutral | $18.63B | 30.67 | 6.53% | ― | -9.99% | -54.75% |